by Dr. Gabe Mirkin | Mar 14, 2024 | Nutrition
Each month North American doctors write more than three million prescriptions for the new weight-loss medications called GLP-1 agonists. Examples include semaglutide in Ozempic and Wegovy and tirzepatide, the drug in Mounjaro and Zepbound. Also each year, these...
by Dr. Gabe Mirkin | Jun 9, 2022 | Nutrition
On May 13, 2022, the U.S. Food and Drug Administration approved tirzepatide (Mounjaro), from Lilly, for the treatment of type 2 diabetes. The drug has not been approved for weight loss, but so far studies show that tirzepatide with a weight loss diet causes...
